SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: arnie h who wrote (1824)4/30/2005 2:42:20 PM
From: richardred  Read Replies (1) | Respond to of 2173
 
I'm also thinking of adding some more in here. I also like the leaps Jan 06 or 07. Nearer term, writing some puts or a buy/write on some calls, should give some risk protection. I wondering if J & J now think they made a mistake, exiting.



To: arnie h who wrote (1824)5/2/2005 10:22:12 PM
From: tom pope  Respond to of 2173
 
A long-acting release formulation of Exenatide (Exenatide LAR) is in the early stages of development.".

Thank you Arnie, I'd missed that. There's a fairly high open interest in the '07 20's, with an implied volatility in the 50's which is not excessive given the potential payoff.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News